Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults with Type 2 Diabetes: Focus on Lixisenatide and Insulin Glargine-Reference-Cited by-同舟云学术

Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults with Type 2 Diabetes: Focus on Lixisenatide and Insulin Glargine

Published:2019-10-23 Issue:12 Volume:36 Page:3321-3339
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Handelsman Yehuda^ORCID,Muskiet Marcel H. A.,Meneilly Graydon S.

Funder

Sanofi

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12325-019-01126-x.pdf

Reference113 articles.

1. IDF Diabetes Atlas. Eighth edition. International Diabetes Federation website. 2017. https://diabetesatlas.org/resources/2017-atlas.html . Accessed May 2019.

2. World Health Organization. Global Deport on Diabetes. 2016. https://apps.who.int/iris/bitstream/handle/10665/204871/9789241565257_eng.pdf;jsessionid=0614B2DFE5379CF79F3E57AA27D91533?sequence=1 . Accessed April 2019.

3. Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2017. Estimates of Diabetes and Its Burden in the United States. Atlanta, GA: Centers for Disease Control and Prevention, U.S. Dept of Health and Human Services; 2017. https://www.cdc.gov/diabetes/data/statistics/statistics-report.html . Accessed April 2019.

4. DeFronzo RA, Eldor R, Abdul-Ghani M. Pathophysiologic approach to therapy in patients with newly diagnosed type 2 diabetes. Diabetes Care. 2013;36(Suppl 2):S127–38.

5. Defronzo RA. Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes. 2009;58:773–95.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current barriers to initiating insulin therapy in individuals with type 2 diabetes;Frontiers in Endocrinology;2024-03-14

2. Effects of age and disease duration on the efficacy and safety of iGlarLixi in Asian people with type 2 diabetes: A post hoc analysis of the LixiLan‐O‐AP and LixiLan‐L‐CN trials;Diabetes, Obesity and Metabolism;2024-01-03

3. Investigating the Binding Efficacy of Snake Venom Proteins as GLP-1 Analogs for Diabetes mellitus Management: An In silico Study;Oriental Journal Of Chemistry;2023-06-30

4. Direct comparison two fixed-ratio combination glucagon-like peptide receptor agonist and basal insulin on glycemic and non glycemic parameters in type 2 diabetes;BMC Endocrine Disorders;2023-02-01

5. Charting the next century of insulin replacement with cell and gene therapies;Med;2021-10